Michela Polidoro (@michelapolid) 's Twitter Profile
Michela Polidoro

@michelapolid

ID: 1545088836291760133

calendar_today07-07-2022 16:54:27

18 Tweet

18 Takipçi

36 Takip Edilen

GUIDO TORZILLI (@torzilliguido) 's Twitter Profile Photo

Proud of my team awarded of the best oral and best poster presentations at KHBPA surgical week 2023 in Busan. Congrats to Dr Flavio Milana Simone Famularo & others for the great job. IHPBA E-AHPBA APHPBA2023 AHPBA SSAT IASGO_1988

Proud of my team awarded of the best oral and best poster presentations at KHBPA surgical week 2023 in Busan. Congrats to Dr Flavio Milana <a href="/simonefamularo/">Simone Famularo</a> &amp; others for the great job. <a href="/IHPBA/">IHPBA</a> <a href="/EAHPBA/">E-AHPBA</a> <a href="/APHPBA2023/">APHPBA2023</a>  <a href="/AHPBA/">AHPBA</a> <a href="/SSATNews/">SSAT</a> <a href="/IASGO_1988/">IASGO_1988</a>
Michela Polidoro (@michelapolid) 's Twitter Profile Photo

After 4 years of hard work and dedication, I've finally achieved my PhD!🎓This journey has been filled with challenges, growth and unforgettable moments. A heartfelt thank you to everyone who supported and believed in me!Excited for the new chapter ahead! Politecnico di Milano Humanitas Milano

After 4 years of hard work and dedication, I've finally achieved my PhD!🎓This journey has been filled with challenges, growth and unforgettable moments. A heartfelt thank you to everyone who supported and believed in me!Excited for the new chapter ahead! <a href="/polimi/">Politecnico di Milano</a> <a href="/HumanitasMilano/">Humanitas Milano</a>
Journal of Hepatology (@jhepatology) 's Twitter Profile Photo

🆕Article in press❕ Incidence and predictors of #hepatocellularcarcinoma in patients with #autoimmunehepatitis Read it here👉bit.ly/46JfrlY #LiverTwitter

🆕Article in press❕

Incidence and predictors of #hepatocellularcarcinoma in patients with #autoimmunehepatitis

Read it here👉bit.ly/46JfrlY

#LiverTwitter
Ana Lleo (@analleo) 's Twitter Profile Photo

🆘 CCA is a deadly cancer 🧬 preclinical research is key! 🆕 CCA-on-a-chip model just published in ⁦JHEP Reports⁩ ⁦EASLnews⁩ 🙏🏻support ⁦⁦Fondazione AIRC per la ricerca sul cancro⁩ ⁦Humanitas University⁩ ⁦Politecnico di Milano⁩ ⁦MiMicLab⁩ ⁦⁦Michela Polidoro⁩ jhep-reports.eu/action/showPdf…

Michela Polidoro (@michelapolid) 's Twitter Profile Photo

Delighted to announce that I've been granted the Umberto Veronesi Foundation fellowship! 🧬🔬 Gratitude to Fondazione Veronesi for this exceptional opportunity!

EASLnews (@easlnews) 's Twitter Profile Photo

New year, new reading materials!🎉 Let’s start 2024 with today’s #readoftheweek about a patient-specific CCA-on-chip platform, which could further elucidate the biological mechanisms involved in CCA and provide an efficient tool for personalised drug testing. Read here this🔓

New year, new reading materials!🎉
Let’s start 2024 with today’s #readoftheweek about a patient-specific CCA-on-chip platform, which could further elucidate the biological mechanisms involved in CCA and provide an efficient tool for personalised drug testing.

Read here this🔓
EASLnews (@easlnews) 's Twitter Profile Photo

Flavio Milana discusses combining blood inflammatory scores predicts survival and reflects the tumor niche in intrahepatic cholangiocarcinoma at #LiverCancerSummit 2024! - The combination of blood inflammatory indexes resulted in the identification of two survival-risk profiles -

<a href="/Fla_doc/">Flavio Milana</a> discusses combining blood inflammatory scores predicts survival and reflects the tumor niche in intrahepatic cholangiocarcinoma at #LiverCancerSummit 2024! 

- The combination of blood inflammatory indexes resulted in the identification of two survival-risk profiles
-
massimo iavarone (@massimoiava) 's Twitter Profile Photo

Flavio Milana elegantly presented data on iCCA: Combining blood inflammatory indexes resulted in the identification of two survival-risk profiles. Adding Ca19.9 identified a high-risk subgroup with an increased risk of recurrence Humanitas Milano Ana Lleo GUIDO TORZILLI EASL Education

<a href="/Fla_doc/">Flavio Milana</a> elegantly presented data on iCCA:
Combining blood inflammatory indexes resulted in the identification of two survival-risk profiles.
Adding Ca19.9 identified a high-risk subgroup with an increased risk of recurrence
<a href="/HumanitasMilano/">Humanitas Milano</a> <a href="/analleo/">Ana Lleo</a> <a href="/TorzilliGuido/">GUIDO TORZILLI</a> <a href="/EASLedu/">EASL Education</a>
Valerie Chew (@valeriechew29) 's Twitter Profile Photo

Day 2 morning session of #EASL #LiverCancerSummit 2024 focusing on really important topics on AI and liq biomarkers for liver cancer. Great talks from @Caldera60373705 Maxime Ronot Arndt Vogel Flavio Milana!

Day 2 morning session of #EASL #LiverCancerSummit 2024 focusing on really important topics on AI and liq biomarkers for liver cancer. Great talks from @Caldera60373705 <a href="/maximeronot/">Maxime Ronot</a> <a href="/ArndtVogel/">Arndt Vogel</a> <a href="/Fla_doc/">Flavio Milana</a>!
EASLnews (@easlnews) 's Twitter Profile Photo

Giulia Milardi presents "Immunosuppressive contribution of tumor-infiltrating B cell subsets in human intrahepatic cholangiocarcinoma and their role in immunotherapy response" at EASL #LiverCancerSummit 2024! B cell subsets may be potential predictive biomarkers in response to

Giulia Milardi presents "Immunosuppressive contribution of tumor-infiltrating B cell subsets in human intrahepatic cholangiocarcinoma and their role in immunotherapy response" at EASL #LiverCancerSummit 2024!

B cell subsets may be potential predictive biomarkers in response to
AMMF (@charityammf) 's Twitter Profile Photo

AMMF-funded research by Dr. Veronica Porreca of Sapienza Università di Roma reveals: thrombospondin 1 (THBS1) & 2 (THBS2) promote malignant behaviour of iCCA cells, while pigment epithelium-derived factor (PEDF) does not affect iCCA cell proliferation and reduces cell adhesion and migration

AMMF-funded research by Dr. Veronica Porreca of <a href="/SapienzaRoma/">Sapienza Università di Roma</a> reveals: thrombospondin 1 (THBS1) &amp; 2 (THBS2) promote malignant behaviour of iCCA cells, while pigment epithelium-derived factor (PEDF) does not affect iCCA cell proliferation and reduces cell adhesion and migration
AMMF (@charityammf) 's Twitter Profile Photo

Cholangiocarcinoma on chip! Dr. Michela Polidoro (Michela Polidoro) from Humanitas Milano shared her fascinating research on developing a microfluid model that mimics the in-vivo-like CCA microenvironment #AMMF2024 #LiverTwitter

Cholangiocarcinoma on chip! Dr. Michela Polidoro (<a href="/MichelaPolid/">Michela Polidoro</a>) from <a href="/HumanitasMilano/">Humanitas Milano</a> shared her fascinating research on developing a microfluid model that mimics the in-vivo-like CCA microenvironment #AMMF2024 #LiverTwitter
Michela Polidoro (@michelapolid) 's Twitter Profile Photo

The Fondazione Veronesi awarded me a grant to continue my research on the effects of immunochemotherapy on Cholangiocarcinoma, using a patient-specific 3D device. Grateful to the Fondazione Veronesi and to everyone supporting scientific research! Humanitas Milano Politecnico di Milano

The <a href="/Fondaz_Veronesi/">Fondazione Veronesi</a> awarded me a grant to continue my research on the effects of immunochemotherapy on Cholangiocarcinoma, using a patient-specific 3D device. 
Grateful to the Fondazione Veronesi and to everyone supporting scientific research!
<a href="/HumanitasMilano/">Humanitas Milano</a> <a href="/polimi/">Politecnico di Milano</a>
Precision-BTC-Network (@precisionbtcnet) 's Twitter Profile Photo

What an inspiring 2 days at the Liquid Biopsy & Precision-BTC Net Conference in beautiful Mallorca! 🌿 We joined an amazing community of researchers, clinicians & advocates that shared key advances from liquid biopsy to AI-driven therapies. Thanks to all who made it possible!🙌

What an inspiring 2 days at the Liquid Biopsy &amp; Precision-BTC Net Conference in beautiful Mallorca! 🌿

We joined an amazing community of researchers, clinicians &amp; advocates that shared key advances from liquid biopsy to AI-driven therapies.

Thanks to all who made it possible!🙌